SCEMBLIX
Active substance: asciminib
TABLET, FILM COATED · ASCIMINIB HYDROCHLORIDE 40 mg/1
United StatesActive
Marketing holder: Novartis Pharmaceuticals Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ASCIMINIB HYDROCHLORIDE · 40 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-7d34-77d7-a217-0bedfa759914,01a12091-6cf4-7370-bc65-b7756875332a,01a12091-6cf9-795d-8e9d-4601100a67a1,01a12095-66b9-7ba6-9e41-7189e93079c4,01a12095-7403-7537-b1e0-95d89585289a;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0078-1098
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0078-1098 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0078-1098 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0078-1098 · Verified 2026-10-09 · open in source